Lopikast Lopinavir and Ritonavir USP Tablets

Send Inquiry

Request To Call Back

Lopikast Lopinavir and Ritonavir USP Tablets

Get a Price/Quote

MOQ : 1 Bottle

Lopikast Lopinavir and Ritonavir USP Tablets Specification

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
60 tablets per bottle

Indication
Treatment of HIV-1 infection

Dosage Form
Oral Tablet

Salt Composition
Lopinavir 200mg and Ritonavir 50mg

Drug Type
Antiretroviral

Ingredients
Lopinavir & Ritonavir USP

Physical Form
Tablets

Function
Antiviral (HIV protease inhibitor)

Recommended For
HIV-1 infected patients in combination with other antiretroviral agents

Dosage
200mg/50 mg

Dosage Guidelines
As directed by the physician; usually 2 tablets taken twice daily

Suitable For
Adults and pediatric patients (as directed by physician)

Quantity
60 tablets per bottle

Storage Instructions
Store below 30C, protect from moisture and light

Regulatory Status
US FDA and WHO GMP approved

Adverse Reactions
Diarrhea, nausea, abdominal pain, increased cholesterol levels

Colour
White to off-white

Shelf Life
36 months from the date of manufacture

Shape
Film-coated tablet

Administration Route
Oral

Prescription Required
Yes

Warning
To be sold by retail on the prescription of a registered medical practitioner only

Lopikast Lopinavir and Ritonavir USP Tablets Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
Pack Of 60 Tablets

Main Domestic Market
All India

Certifications
Brand Name : Lopikast Content : Lopinavir & Ritonavir USP Form : Tablets Strength : 200mg/50 mg Packing : Pack Of 60 Tablets Manufactured By-: Aprazer

About Lopikast Lopinavir and Ritonavir USP Tablets

Specification :-

Brand Name : Lopikast

Content : Lopinavir & Ritonavir USP

Form : Tablets

Strength : 200mg/50 mg

Packing : Pack Of 60 Tablets

Manufactured By-: Aprazer

Note :- Lopikast Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.

How Lopikast Works

Lopikast combines two potent HIV protease inhibitors, Lopinavir and Ritonavir, which interfere with viral replication. By inhibiting the viruss ability to multiply within the body, this medication helps slow the progression of HIV-1 infection and supports immune system health. It is designed for use alongside other antiretroviral medicines for maximum benefit.

Administration and Dosage Guidelines

Lopikast must be taken orally, usually two tablets twice daily, or as directed by your physician. It is crucial to follow the prescribed dosage and duration, and the tablets should be stored below 30C, away from moisture and light. Administration should only occur under medical supervision, especially for pediatric patients.

Safety Precautions and Storage

Lopikast is a prescription-only medicine, sold exclusively by registered medical practitioners. Adverse reactions may include diarrhea, nausea, abdominal pain, and elevated cholesterol levels. Always store Lopikast below 30C, protected from moisture and light, and keep it out of the reach of children for safety. Regular monitoring is recommended during treatment.

FAQs of Lopikast Lopinavir and Ritonavir USP Tablets:

Q: How should Lopikast Lopinavir and Ritonavir USP Tablets be taken for effective HIV-1 treatment?

A: Lopikast tablets are taken orally, typically two tablets twice a day with or without food, as advised by your physician. Regular monitoring and adherence to the prescribed dosage are essential for optimal effectiveness.

Q: What are the main benefits of using Lopikast in HIV-1 therapy?

A: Lopikast helps control HIV-1 infection by inhibiting viral replication and supporting immune system function. Used in combination with other antiretroviral agents, it slows disease progression and improves overall health outcomes.

Q: When should Lopikast treatment be initiated?

A: Treatment with Lopikast should begin upon the recommendation of a registered medical practitioner, once a diagnosis of HIV-1 infection is confirmed. Early initiation, alongside a comprehensive antiretroviral regimen, enhances treatment efficacy.

Q: Where should Lopikast tablets be stored to maintain efficacy?

A: Lopikast should be stored below 30C, in a dry place away from direct light and moisture. Proper storage prevents degradation and preserves shelf life for up to 36 months from the date of manufacture.

Q: What process ensures Lopikasts quality and safety?

A: Lopikast is manufactured under the strict guidelines of US FDA and WHO GMP certifications, guaranteeing pharmaceutical quality, safety, and efficacy for patients worldwide.

Q: Is Lopikast suitable for both adults and children?

A: Yes, Lopikast is suitable for adults and pediatric patients when administered as directed by a qualified physician, ensuring dosing appropriateness according to patient age and health status.

Q: What adverse reactions can occur during Lopikast use?

A: Possible adverse effects include diarrhea, nausea, abdominal pain, and increased cholesterol levels. If these symptoms appear or persist, consult your healthcare provider for further management.

Tell us about your requirement